Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$45.8 - $85.4 $458 - $854
10 Added 35.71%
38 $2,000
Q1 2022

May 13, 2022

BUY
$62.2 - $84.4 $248 - $337
4 Added 16.67%
28 $2,000
Q4 2021

Feb 11, 2022

SELL
$73.71 - $87.86 $73 - $87
-1 Reduced 4.0%
24 $2,000
Q3 2021

Feb 11, 2022

SELL
$77.92 - $102.4 $1,012 - $1,331
-13 Reduced 34.21%
25 $2,000
Q2 2021

Feb 11, 2022

BUY
$92.19 - $115.71 $1,843 - $2,314
20 Added 111.11%
38 $4,000
Q1 2021

Feb 08, 2022

BUY
$106.9 - $167.73 $1,924 - $3,019
18 New
18 $2,000

Others Institutions Holding RARE

About Ultragenyx Pharmaceutical Inc.


  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $2.74B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.